Agilent Technologies

Advanced Analytical Technologies, Inc. is now Agilent Technologies. We are excited to be able to provide automated electrophoresis instruments to our customers offering them all the opportunities and benefits this merger will bring them.

Agilent develops and manufactures capillary electrophoresis based solutions for nucleic acid analysis. The instruments employ parallel capillary electrophoresis, with UV absorbance or fluorescence detection, to streamline nucleic acid analysis and alleviate analytic bottlenecks. Our nucleic acid analysis solutions are ideal for any application, from NGS library QC and CRISPR/Cas9 mutation detection to determining oligonucleotide purity and genomic DNA analysis.

Upcoming Events

Recent News

How to place orders after November 1, 2018

As a part of the Agilent family, we will be undergoing a few changes. Starting November 1, 2018 orders for Fragment Analyzers and any other products you buy from Advanced Analytical must be submitted to Agilent.

Fragment Analyzer featured in R&D Article

Steve Siembieda, Vice President of Commercialization at Advanced Analytical – A part of Agilent, recently penned an article in R&D. The article discusses the importance of proper nucleic acid QC during NGS library preparation using cfDNA as an example.

AATI is Now Part of the Agilent Family

Advanced Analytical Technologies, Inc. is excited to announce we are now a part of the Agilent family. With the completion of the transaction, AATI’s 109 employees are now part of Agilent’s newly formed Biomolecular Analysis Division. This division integrates capillary electrophoresis solutions from AATI with Agilent’s microfluidics business.

Read the complete press release.